메뉴 건너뛰기




Volumn 58, Issue 11, 2014, Pages 6518-6527

Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections

Author keywords

[No Author keywords available]

Indexed keywords

3 CYCLOPENTYL N' [5 FLUORO 2 METHYL 6 (OCTAHYDROPYRAZINO[2,1 C][1,4]OXAZIN 8 YL) 4 PYRIMIDINYL] 2 (N FORMYL N HYDROXYAMINOMETHYL)PROPIONOHYDRAZIDE; BACTERIAL ENZYME; CREATINE KINASE; GLUCOSE; HEMOGLOBIN; LINEZOLID; PEPTIDE DEFORMYLASE; ACETAMIDE DERIVATIVE; AMIDASE; ANTIINFECTIVE AGENT; BETA LACTAMASE; CYTOCHROME P450 3A; CYTOCHROME P450 3A INHIBITOR; FUSED HETEROCYCLIC RINGS; HYDROXAMIC ACID; LANOPEPDEN; OXAZOLIDINONE DERIVATIVE;

EID: 84908587320     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03360-14     Document Type: Article
Times cited : (27)

References (26)
  • 1
    • 84555190775 scopus 로고    scopus 로고
    • Insights into antibiotic resistance through metagenomic approaches
    • Schmieder R, Edwards R. 2012. Insights into antibiotic resistance through metagenomic approaches. Future Microbiol. 7:73-89. http://dx.doi.org/10.2217/fmb.11.135.
    • (2012) Future Microbiol , Issue.7 , pp. 73-89
    • Schmieder, R.1    Edwards, R.2
  • 2
    • 77957980707 scopus 로고    scopus 로고
    • Origins and evolution of antibiotic resistance
    • Davies J, Davies D. 2010. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74:417-433. http://dx.doi.org/10.1128/MMBR .00016-10.
    • (2010) Microbiol. Mol. Biol. Rev , Issue.74 , pp. 417-433
    • Davies, J.1    Davies, D.2
  • 3
    • 79953710021 scopus 로고    scopus 로고
    • Novel classes of antibiotics or more of the same?
    • Coates ARM, Halls G, Hu Y. 2011. Novel classes of antibiotics or more of the same? Br. J. Pharmacol. 163:184-194. http://dx.doi.org/10.1111/j .1476-5381.2011.01250.x.
    • (2011) Br. J. Pharmacol , Issue.163 , pp. 184-194
    • Arm, C.1    Halls, G.2    Hu, Y.3
  • 4
    • 84879021964 scopus 로고    scopus 로고
    • Anonymous. Pfizer, Inc., New York, NY
    • Anonymous. 2012. Zyvox package insert. Pfizer, Inc., New York, NY.
    • (2012) Zyvox Package Insert
  • 5
    • 84873642637 scopus 로고    scopus 로고
    • Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: The ESTABLISH-1 randomized trial
    • Prokocimer P, De Anda C, Fang E, Mehra P, Das A. 2013. Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial. JAMA 309:559-569. http://dx.doi.org/10.1001/jama.2013.241.
    • (2013) JAMA , vol.309 , pp. 559-569
    • Prokocimer, P.1    De Anda, C.2    Fang, E.3    Mehra, P.4    Das, A.5
  • 8
    • 84870158882 scopus 로고    scopus 로고
    • Potent activity of GSK1322322, a novel peptide deformylase inhibitor, in a Haemophilus influenzae and Streptococcus pneumoniae respiratory tract infection model, abstr. F1-2115
    • Boston, MA, 12 to 15 September 2010
    • Lewandowski T, Peters T, Simon N, Kulkarni S. 2010. Potent activity of GSK1322322, a novel peptide deformylase inhibitor, in a Haemophilus influenzae and Streptococcus pneumoniae respiratory tract infection model, abstr. F1-2115. Proceedings of the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, 12 to 15 September 2010.
    • (2010) Proceedings of the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
    • Lewandowski, T.1    Peters, T.2    Simon, N.3    Kulkarni, S.4
  • 9
    • 80355137256 scopus 로고    scopus 로고
    • Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor
    • Ross JE, Scangarella-Oman NE, Miller LA, Sader HS, Jones RN. 2011. Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor. J. Clin. Microbiol. 49:3928-3930. http://dx.doi.org/10.1128/JCM.01213-11.
    • (2011) J. Clin. Microbiol , Issue.49 , pp. 3928-3930
    • Ross, J.E.1    Scangarella-Oman, N.E.2    Miller, L.A.3    Sader, H.S.4    Jones, R.N.5
  • 11
    • 84870158882 scopus 로고    scopus 로고
    • Potent activity of GSK1322322, a novel peptide deformylase inhibitor, after oral dosing in a murine multi-drug resistant Staphylococcus aureus infection model, abstr. F1-2113
    • Boston, MA, 12 to 15 September 2010
    • Lewandowski T, DeMarsh P, Peters T, Kulkarni S. 2010. Potent activity of GSK1322322, a novel peptide deformylase inhibitor, after oral dosing in a murine multi-drug resistant Staphylococcus aureus infection model, abstr. F1-2113. Proceedings of the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, 12 to 15 September 2010.
    • (2010) Proceedings of the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
    • Lewandowski, T.1    Demarsh, P.2    Peters, T.3    Kulkarni, S.4
  • 12
    • 84876223355 scopus 로고    scopus 로고
    • Single-dose safety, tolerability, and pharmacokinetics of the antibiotic GSK1322322, a novel peptide deformylase inhibitor
    • Naderer OJ, Dumont E, Zhu J, Kurtinecz M, Jones LS. 2013. Single-dose safety, tolerability, and pharmacokinetics of the antibiotic GSK1322322, a novel peptide deformylase inhibitor. Antimicrob. Agents Chemother. 57: 2005-2009. http://dx.doi.org/10.1128/AAC.01779-12.
    • (2013) Antimicrob. Agents Chemother , vol.57 , pp. 2005-2009
    • Naderer, O.J.1    Dumont, E.2    Zhu, J.3    Kurtinecz, M.4    Jones, L.S.5
  • 13
    • 84877859809 scopus 로고    scopus 로고
    • Effect of H2 blockade and food on single-dose pharmacokinetics of GSK1322322, a peptide deformylase inhibitor antibacterial
    • Naderer OJ, Dumont E, Zhu J, Kurtinecz M, Jones LS. 2013. Effect of H2 blockade and food on single-dose pharmacokinetics of GSK1322322, a peptide deformylase inhibitor antibacterial. Antimicrob. Agents Chemother. 57:2556-2561. http://dx.doi.org/10.1128/AAC.02505-12.
    • (2013) Antimicrob. Agents Chemother , Issue.57 , pp. 2556-2561
    • Naderer, O.J.1    Dumont, E.2    Zhu, J.3    Kurtinecz, M.4    Jones, L.S.5
  • 14
    • 84880750563 scopus 로고    scopus 로고
    • Safety, tolerability and pharmacokinetics of repeat dosing of the antibiotic GSK1322322, a peptide deformylase inhibitor: A randomized placebocontrolled study
    • Naderer OJ, Dumont E, Zhu J, Kurtinecz M, Jones LS. 2013. Safety, tolerability and pharmacokinetics of repeat dosing of the antibiotic GSK1322322, a peptide deformylase inhibitor: a randomized placebocontrolled study. J. Antimicrob. Chemother. 68:1901-1909. http://dx.doi.org/10.1093/jac/dkt097.
    • (2013) J. Antimicrob. Chemother , vol.68 , pp. 1901-1909
    • Naderer, O.J.1    Dumont, E.2    Zhu, J.3    Kurtinecz, M.4    Jones, L.S.5
  • 15
    • 84891505001 scopus 로고    scopus 로고
    • Safety, tolerability, and pharmacokinetics of oral and intravenous administration of GSK1322322, a peptide deformylase inhibitor
    • Naderer OJ, Jones LS, Zhu J, Kurtinecz M, Dumont E. 2013. Safety, tolerability, and pharmacokinetics of oral and intravenous administration of GSK1322322, a peptide deformylase inhibitor. J. Clin. Pharmacol. 53: 1168-1176. http://dx.doi.org/10.1002/jcph.150.
    • (2013) J. Clin. Pharmacol , Issue.53 , pp. 1168-1176
    • Naderer, O.J.1    Jones, L.S.2    Zhu, J.3    Kurtinecz, M.4    Dumont, E.5
  • 16
    • 84866648642 scopus 로고    scopus 로고
    • Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: Update from the Biomarkers Consortium of the Foundation for the National Institutes of Health
    • Talbot GH, Powers JH, Fleming TR, Siuciak JA, Bradley J, Boucher H, CABP-ABSSSI Project Team. 2012. Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of Health. Clin. Infect. Dis. 55:1114-1121. http://dx.doi.org/10.1093/cid/cis566.
    • (2012) Clin. Infect. Dis , Issue.55 , pp. 1114-1121
    • Talbot, G.H.1    Powers, J.H.2    Fleming, T.R.3    Siuciak, J.A.4    Bradley, J.5    Boucher, H.6    Project Team, C.7
  • 18
    • 6444222075 scopus 로고    scopus 로고
    • Detection of Panton-Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: Clinical and epidemiological aspects
    • Johnsson D, Mölling P, Stralin K, Söderquist B. 2004. Detection of Panton-Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects. Clin. Microbiol. Infect. 10: 884-889. http://dx.doi.org/10.1111/j.1469-0691.2004.00976.x.
    • (2004) Clin. Microbiol. Infect , vol.10 , pp. 884-889
    • Johnsson, D.1    Mölling, P.2    Stralin, K.3    Söderquist, B.4
  • 19
    • 0033496604 scopus 로고    scopus 로고
    • Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia
    • Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter M-O, Gauduchon V, Vandenesch F, Etienne J. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:1128-1132. http://dx.doi.org/10.1086/313461.
    • (1999) Clin. Infect. Dis , vol.29 , pp. 1128-1132
    • Lina, G.1    Piémont, Y.2    Godail-Gamot, F.3    Bes, M.4    Peter, M.-O.5    Gauduchon, V.6    Vandenesch, F.7    Etienne, J.8
  • 20
    • 0242677610 scopus 로고    scopus 로고
    • Pulsed-field gel electrophoresis typing of oxacillinresistant Staphylococcus aureus isolates from the United States: Establishing a national database
    • McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. 2003. Pulsed-field gel electrophoresis typing of oxacillinresistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120. http://dx.doi.org/10.1128/JCM.41.11.5113-5120.2003.
    • (2003) J. Clin. Microbiol , vol.41 , pp. 5113-5120
    • McDougal, L.K.1    Steward, C.D.2    Killgore, G.E.3    Chaitram, J.M.4    McAllister, S.K.5    Tenover, F.C.6
  • 21
    • 34447272463 scopus 로고    scopus 로고
    • Allelic variation in genes encoding Panton-Valentine leukocidin from community-associated Staphylococcus aureus
    • Wolter DJ, Tenover FC, Goering RV. 2007. Allelic variation in genes encoding Panton-Valentine leukocidin from community-associated Staphylococcus aureus. Clin. Microbiol. Infect. 13:827-830. http://dx.doi.org/10.1111/j.1469-0691.2007.01763.x.
    • (2007) Clin. Microbiol. Infect , vol.13 , pp. 827-830
    • Wolter, D.J.1    Tenover, F.C.2    Goering, R.V.3
  • 24
    • 84904718296 scopus 로고    scopus 로고
    • Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): A randomised, double-blind, phase 3, non-inferiority trial
    • Moran GJ, Fang E, Corey GR, Das AF, De Anda C, Prokocimer P. 2014. Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial. Lancet Infect. Dis. 14:696-705. http://dx.doi.org/10.1016/S1473-3099(14)70737-6.
    • (2014) Lancet Infect. Dis , vol.14 , pp. 696-705
    • Moran, G.J.1    Fang, E.2    Corey, G.R.3    Das, A.F.4    De Anda, C.5    Prokocimer, P.6
  • 25
    • 81555200433 scopus 로고    scopus 로고
    • Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection
    • Covington P, Davenport JM, Andrae D, O'Riordan W, Liverman L, McIntyre G, Almenoff J. 2011. Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection. Antimicrob. Agents Chemother. 55:5790-5797. http://dx.doi.org/10.1128/AAC.05044-11.
    • (2011) Antimicrob. Agents Chemother , Issue.55 , pp. 5790-5797
    • Covington, P.1    Davenport, J.M.2    Andrae, D.3    O'Riordan, W.4    Liverman, L.5    McIntyre, G.6    Almenoff, J.7
  • 26
    • 84908587678 scopus 로고    scopus 로고
    • Pharmacokinetics/pharmacodynamics (PK/PD) of peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus in a rat abscess model, abstr. P920
    • Berlin, Germany, 27 to 30 April 2013
    • Lewandowski T, Hoover J, Rittenhouse S. 2013 Pharmacokinetics/pharmacodynamics (PK/PD) of peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus in a rat abscess model, abstr. P920. 23rd European Congress of Clinical Microbiology and Infectious Diseases, Berlin, Germany, 27 to 30 April 2013.
    • (2013) 23rd European Congress of Clinical Microbiology and Infectious Diseases
    • Lewandowski, T.1    Hoover, J.2    Rittenhouse, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.